Search PubMed⌕ Search

PubMed · 926893

Pulmonary embolism.

Abstract

It is reasonable to conclude by considering an approach to the diagnosis and treatment of pulmonary embolism. When the diagnosis is suspect, and in the absence of contraindications, or hemodynamic instability, treatment with heparin may be begun and an arterial blood gas and perfusion lung scan obtained. If the Pao2 and perfusion scan are normal, it is unlikely that significant pulmonary embolism has occurred. The presence of a perfusion scan defect and hypoxemia should suggest that a ventilation scan and/or evaluation for deep vein thrombosis is performed. A ventilation scan which shows absence of ventilation in areas where there is a perfusion defect, or failure to demonstrate deep vein disease, strongly mitigate against the diagnosis of pulmonary embolism. If the diagnosis is in doubt, pulmonary angiography should be performed. If the patient presents in shock, an angiogram should be performed, while heparin is administered and supportive measures are begun. If anticoagulants are contraindicated, or if re-embolization occurs after adequate anticoagulant therapy, consideration should be given to placement of a transcaval umbrella filter.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Reichel. 1977. Pulmonary embolism.. https://doi.org/10.1016/s0025-7125(16)31263-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Thermally reversible pluronic/heparin nanocapsules exhibiting 1000-fold volume transition.

Novel Pluronic/heparin composite nanocapsules that exhibit a thermally responsible swelling and deswelling behavior were synthesized. Pluronic F-127 preactivated with p-nitrophenyl chloroformate at its two terminal hydroxyl groups was dissolved in a methylene chloride phase. The organic phase was dispersed in an aqueous phase containing heparin. At an organic/aqueous interface, Pluronic-cross-linked heparin nanocapsules were produced. They exhibited a 1000-fold volume transition (ca. 336 nm at 25 degrees C; ca. 32 nm at 37 degrees C), and a reversible swelling and deswelling behavior when the temperature was cycled between 20 and 37 degrees C. The reversible volume transition of Pluronic nanocapsules was caused by micellization and demicellization of cross-linked Pluronic polymer chains within the nanocapsule structure in response to temperature. The morphological characters were investigated with transmission electron microscopy and small angle neutron scattering. Pluronic/heparin nanocapsules had an aqueous fluid-filled hollow interior with a surrounding shell layer below the critical temperature, but they became a collapsed core/shell structure similar to that of Pluronic micelles above it.

Heparin↗